Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Circular RNAs (circRNAs) show promise as biomarkers for breast cancer detection and treatment. This review highlights their potential in early diagnosis, prognosis, and understanding drug resistance in breast cancer.
Area Of Science
- Biochemistry
- Molecular Biology
- Oncology
Background
- Breast cancer is a leading cause of death in women globally.
- Circular RNAs (circRNAs) are stable noncoding RNAs found in various bodily fluids.
- Aberrant circRNA expression is linked to breast cancer development.
Purpose Of The Study
- To provide a comprehensive overview of circRNAs as biomarkers in breast cancer.
- To discuss the role of circRNAs in early diagnosis, prognosis, and molecular subtyping.
- To explore circRNAs in relation to metastasis and drug resistance.
Main Methods
- Literature review of recent studies on circRNAs in breast cancer.
- Analysis of circRNA expression patterns and their clinical significance.
- Synthesis of current research on circRNA functions in breast cancer progression.
Main Results
- CircRNAs demonstrate potential as sensitive and specific biomarkers for breast cancer.
- Abnormal circRNA levels correlate with tumor stage, patient prognosis, and treatment response.
- CircRNAs are implicated in various aspects of breast cancer, including metastasis and drug resistance.
Conclusions
- CircRNAs represent a promising avenue for novel breast cancer biomarkers.
- Further research is warranted to translate circRNA findings into clinical applications.
- CircRNAs may offer new therapeutic targets for breast cancer management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
